These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12579496)

  • 1. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer].
    Zhang FR; He XB; Yang YH; Xie W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):31-4. PubMed ID: 12579496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of imprinting in IGF2 in colorectal carcinoma assessed by microdissection.
    Maenaka S; Hikichi T; Imai MA; Minamoto T; Kawahara E
    Oncol Rep; 2006 Apr; 15(4):791-5. PubMed ID: 16525660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The imprinting status and expression of insulin-like growth factor 2 gene in human hepatocellular carcinoma].
    He WZ; Qin Y; Li B; Liu JY; Sun ZL; Sun ZF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):466-9. PubMed ID: 15291100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the expression and genomic imprinting status of insulin-like growth factor 2 gene in hepatocellular carcinoma].
    Li H; Zhang N
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):347-9. PubMed ID: 15225429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR.
    Xu W; Fan H; He X; Zhang J; Xie W
    J Exp Clin Cancer Res; 2006 Dec; 25(4):543-7. PubMed ID: 17310846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of IGF2 gene imprinting in breast and colorectal cancer by allele specific-PCR.
    Yun K; Soejima H; Merrie AE; McCall JL; Reeve AE
    J Pathol; 1999 Apr; 187(5):518-22. PubMed ID: 10398115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
    Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer.
    Zuo QS; Yan R; Feng DX; Zhao R; Chen C; Jiang YM; Cruz-Correa M; Casson AG; Kang XD; Han F; Chen T
    Mol Carcinog; 2011 May; 50(5):390-6. PubMed ID: 21268128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas.
    Wu HK; Squire JA; Catzavelos CG; Weksberg R
    Biochem Biophys Res Commun; 1997 Jun; 235(1):123-9. PubMed ID: 9196048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2.
    Sasaki J; Konishi F; Kawamura YJ; Kai T; Takata O; Tsukamoto T
    Int J Cancer; 2006 Jul; 119(1):80-3. PubMed ID: 16432831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma.
    Li Y; Meng G; Huang L; Guo QN
    Hum Pathol; 2009 Oct; 40(10):1441-7. PubMed ID: 19427670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genomic imprinting of insulin-like growth factor II in prostate cancer and its clinical significance].
    Liu ZW; Zhou FJ; Luo YM; Qin ZK; Wang DJ; Luo JH; Han H; Li YH; Wang H
    Ai Zheng; 2006 Jun; 25(6):765-70. PubMed ID: 16764778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
    Vu TH; Chuyen NV; Li T; Hoffman AR
    Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of imprinting in hepatoblastoma.
    Rainier S; Dobry CJ; Feinberg AP
    Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of imprinting of IGF2 in Ewing's sarcoma.
    Zhan S; Shapiro DN; Helman LJ
    Oncogene; 1995 Dec; 11(12):2503-7. PubMed ID: 8545106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability.
    Cui H; Horon IL; Ohlsson R; Hamilton SR; Feinberg AP
    Nat Med; 1998 Nov; 4(11):1276-80. PubMed ID: 9809551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma.
    Nonomura N; Nishimura K; Miki T; Kanno N; Kojima Y; Yokoyama M; Okuyama A
    Cancer Res; 1997 Jul; 57(13):2575-7. PubMed ID: 9205056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer.
    Takano Y; Shiota G; Kawasaki H
    Oncology; 2000 Sep; 59(3):210-6. PubMed ID: 11053988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma].
    Wu J; Qin Y; Li B; He WZ; Sun ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):49-52. PubMed ID: 17294726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.